Alto Neuroscience ANRO Debt Issuance Costs
Debt Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:PaymentsOfDebtIssuanceCosts.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's debt issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's debt issuance costs?
- Alto Neuroscience (ANRO) reported debt issuance costs of $0 in Q1 2026.
- How has Alto Neuroscience's debt issuance costs changed year-over-year?
- Alto Neuroscience's debt issuance costs decreased by 100.0% year-over-year, from $127K to $0.
- What does debt issuance costs mean?
- Cash paid for fees, legal costs, and underwriting discounts associated with issuing new debt.